Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Probiotics wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Likely helps
30 of 39 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Agarikon and Probiotics have evidence — compare verdict strength side-by-side.
500-1500mg extract daily
With or without food
Agarikon extract
10-20 billion CFU
With or without food (strain-dependent), Same time daily for consistency
Capsules with multiple strains
4-8 weeks
Ongoing
N/A
2-4 weeks
4-8 weeks
4-8 weeks
First 1-2 weeks
Fomitopsis officinalis: a Species of Arboreal Mushroom with Promising Biological and Medicinal Properties
Chemistry & biodiversity (2020) · Systematic review
Because of its valuable biological properties and its use in 18th and 19th-century pharmacy, Fomitopsis officinalis used to be mass-collected.
An antitumor fungal polysaccharide from Fomitopsis officinalis by activating immunity and inhibiting angiogenesis
International journal of biological macromolecules (2024) · Observational
The following mechanism examination discovered that FOBP50-1 interacted with TLR-4, PD-1, and VEGF to activate immunity and inhibit angiogenesis according to a series of cell, transgenic zebrafish, and surface plasmon resonance (SPR) experiments.
A fungal polysaccharide from Fomitopsis officinalis as a multi-target molecule to combat cancer
International journal of biological macromolecules (2024) · Observational
The following mechanistic analysis discovered that the in vivo antitumor effect was linked to immune activation and angiogenesis inhibition.
Preventive Effect of Probiotics on Oral Mucositis Induced by Cancer Treatment: A Systematic Review and Meta-Analysis
International journal of molecular sciences (2022) · Meta analysis · n=708
Three trials using Lactobacilli-based probiotics reported that the incidence of oral mucositis in the probiotic group was significantly low (risk ratio [RR] = 0.84, 95% confidence interval [CI] = 0.77−0.93, p = 0.0004).
Probiotics for treating acute infectious diarrhoea
The Cochrane database of systematic reviews (2020) · Meta analysis · n=12127
Effect size was similar in the sensitivity analysis and marked heterogeneity persisted.
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
The Cochrane database of systematic reviews (2017) · Meta analysis · n=9955
A complete case analysis (i.e. participants who completed the study) among trials investigating CDAD (31 trials, 8672 participants) suggests that probiotics reduce the risk of CDAD by 60%.
Evidence primarily from animal studies and in-vitro research. Polysaccharide compounds show immunomodulatory activity through TLR-4 interactions. Human clinical data limited. Conservative estimates due to lack of RCT data.
Based on meta-analyses showing benefits for IBS and digestive symptoms. Effect sizes varied considerably between studies with low to very low certainty of evidence. Initial GI symptoms common when starting but typically resolve within 1-2 weeks.
AI-estimated from published studies. Interpret as directional guidance.
Probiotics has a higher evidence score (9/10 vs 3.5/10) and wins in 3 of 3 categories.
For reduce inflammation, Probiotics has a higher relevance score (95 vs 45).
No known interactions between Agarikon and Probiotics have been documented in our database. However, always consult a healthcare provider before combining supplements.